SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: StockMiser who wrote (12)1/28/1999 1:50:00 PM
From: Street Walker  Read Replies (1) | Respond to of 5582
 
Future --

So just with their old product chewing gum line, target was $24

Now with Zicam, gosh, I'm having a difficult time figuring out
how much this adds to the 12 month price.

It all depends upon how much GUMM makes on each sale.
The Cold market is a BIG business and its a matter of what
percent of the common colds they will treat this year, and
the huge growth in future years as we think globally.

Regards,
S.W.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News